Page 1 of Clinical Trials for ( Tibotec Pharmaceuticals AND Ireland ) [SPONSOR-COLLABORATORS], 77 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
TMC114-TiDP29-C228 - A Safety Study to Evaluate the Antiviral Activity of Darunavir (DRV) in Combination With Ritonavir (Rtv) in HIV 1 Infected Children From 3 Years to Below 6 Years of Age
Last Updated: February 10, 2011
Condition(s): HIV Infections
2
Completed
A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents
Last Updated: May 15, 2012
Condition(s): HIV-1 Infection
3
Completed
TMC435-TiDP16-C112 - Interaction Trial With Antidepressants
Last Updated: March 20, 2012
Condition(s): Hepatitis C Virus
4
Completed
TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use
Last Updated: May 18, 2011
Condition(s): HIV Infection
5
Completed
Innovation-TiFP4-C101: A Study to Evaluate the Pharmacokinetics of TMC114 and TMC41629 After a Single Oral Dose of 2 Controlled-release Coformulations as Compared to an Immediate-release Coformulation of TMC114/TMC41629
Last Updated: April 26, 2010
Condition(s): HIV-I
6
Completed
A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive Ovysmen
Last Updated: February 14, 2012
Condition(s): Hepatitis C Virus
7
Completed
TMC278-C204: TMC278 in Treatment Naive HIV-1 Infected Subjects
Last Updated: May 3, 2012
Condition(s): HIV Infection
8
Completed
TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.
Last Updated: April 26, 2010
Condition(s): HIV; AIDS; Hepatic Impairment
9
Completed
TMC435-TiDP16-C116 - Relative Bioavailability and Food Effect Study
Last Updated: November 1, 2011
Condition(s): Hepatitis C
10
Completed
TMC435-TiDP16-C205: A Phase II Study of TMC435 in Combination With Pegylated Interferon Alpha-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment
Last Updated: March 15, 2012
Condition(s): Hepatitis C
11
Completed
TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart Conduction and Heart Rhythm) in Healthy Volunteers.
Last Updated: June 8, 2011
Condition(s): Human Volunteers
12
Completed
TMC114-TiDP29-C169: Bioavailability and Pharmacokinetics Trial Comparing Darunavir Pediatric Suspension Formulation to Current Darunavir Tablet
Last Updated: June 8, 2011
Condition(s): Pharmacokinetics
13
Terminated
TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously
Last Updated: April 22, 2010
Condition(s): HIV Infections
14
Terminated
PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354.
Last Updated: April 26, 2010
Condition(s): HIV Infections
15
Completed
TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy.
Last Updated: June 8, 2011
Condition(s): HIV; Pharmacokinetics
16
Completed
TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.
Last Updated: June 8, 2011
Condition(s): HIV
17
Completed
TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose Administration
Last Updated: March 19, 2012
Condition(s): Hepatitis C Virus
18
Completed
An Open-label Trial With TMC125 in Patients Who Have Virologically Failed in a DUET Trial (TMC125-C206 or TMC125-C216).
Last Updated: May 4, 2012
Condition(s): HIV-1
19
Completed
TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
Last Updated: April 26, 2010
Condition(s): HIV; AIDS; Oral Contraceptive
20
Completed
A Pediatric Trial to Provide Dose Recommendation of TMC114/Rtv in HIV-1 Infected Children and Adolescents
Last Updated: November 25, 2011
Condition(s): HIV-1; HIV Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Tibotec+Pharmaceuticals%2C+Ireland

Page 1 of Clinical Trials for ( Tibotec Pharmaceuticals AND Ireland ) [SPONSOR-COLLABORATORS], 77 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About